Dapagliflozin tablets (brand name options include Farxiga and Forxiga) are a prescription medication used to treat several serious conditions in adults, and type 2 diabetes in children and adolescents. Key indications for dapagliflozin include its use as an addition to diet and exercise for improved blood sugar control in adults and children aged 10 and above with type 2 diabetes. It is also prescribed to adults with heart failure to lower the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits, regardless of their ejection fraction. Additionally, dapagliflozin is used in adults with chronic kidney disease who are at risk of progression, with or without type 2 diabetes, to reduce the risk of a sustained decline in kidney function (eGFR), end-stage kidney disease, cardiovascular death, and hospitalization for heart failure.